Sector | Finance | Compare with Sector peers |
Industry | Finance - Investment | Compare with Industry peers |
Website | http://www.prismmedico.in | |
Market Cap | 14.42 Cr. | |
Enterprise Value(EV) | Cr. | - |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.16 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 147.13 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 15.11 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 25.08 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 0.95 | Calculated using Price: 23.78 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.61 Cr. | 6,063,428 Shares |
FaceValue | 10 | |
About Prism Medico and Pharmacy Ltd. | ||
The main object of the company was to carry on the trading in goods and commodities.. During the year ended March 31, 2008 the company earned Interest Income from loans and advances given and is presently engaged in the investing in shares and other securities and other financing activities. |
1 Day |
|
+2.57% |
1 Week |
|
-2.44% |
1 Month |
|
-5.76% |
3 Month |
|
-25.08% |
6 Month |
|
-21.30% |
1 Year |
|
-8.79% |
2 Year |
|
+194.44% |
5 Year |
|
-31.52% |
10 Year |
|
+35.44% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -0.55 | -0.51 | -3.15 | -0.15 | 2.85 | -0.38 | -1 | -2.9 | -0.55 | |
Return on Capital Employed (%) | -0.55 | -0.49 | -3.11 | 0.37 | 2.26 | -0.52 | -1.35 | -3.91 | -0.74 | |
Return on Assets (%) | -0.54 | -0.47 | -3.05 | -0.15 | 2.47 | -0.26 | -0.6 | -2.18 | -0.55 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 2 | 2 | 13 | 13 | 13 | 13 | 13 | 13 | 15 | 15 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Curr. Liab. | 0 | 0 | 0 | 0 | 4 | 9 | 9 | 0 | 0 | 0 | |
Minority Int. | |||||||||||
Equity & Liab. | 2 | 2 | 13 | 13 | 17 | 22 | 21 | 12 | 15 | 15 | |
Non Curr. Assets | 0 | 10 | 11 | 10 | 2 | 2 | 0 | 0 | 5 | ||
Curr. Assets | 2 | 2 | 3 | 2 | 7 | 20 | 19 | 12 | 15 | 11 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 2 | 2 | 13 | 13 | 17 | 22 | 21 | 12 | 15 | 15 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 0 | 0 | 21 | 36 | 27 | 17 | 8 | 1 | 4 | ||
Other Income | 0 | 0 | 0 | 0 | 0 | ||||||
Total Income | 0 | 0 | 0 | 21 | 37 | 27 | 17 | 8 | 1 | 4 | |
Total Expenditure | 0 | 0 | 0 | -21 | -36 | -27 | -17 | -9 | -1 | -4 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Interest | 0 | ||||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Adjusted EPS | 0 | 0 | 0 | 0 | 1 | 0 | 0 | -1 | 0 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | -1 | -1 | -4 | 0 | -2 | 3 | ||
Cash Fr. Inv. | 0 | 0 | 0 | 1 | 4 | 0 | 2 | -3 | |||
Cash Fr. Finan. | 0 | 0 | 1 | 0 | |||||||
Net Change | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | |||
Cash & Cash Eqvt | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Sat, 20 Apr 2024
Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. Dear Sir/Madam With reference to the captioned subject please find the attached report on investor complaints for the quarter ended 31st March 2024. You are requested to kindly take the same on record and oblige. Thanking You. |
Sat, 13 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Dear Sir/Madam Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 we hereby furnish the confirmation certificate issued by the Registrar and Share Transfer Agent (RTA) for the quarter ended 31st March 2024. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You. |
Mon, 01 Apr 2024
Closure of Trading Window Dear Sir/Madam Pursuant to Code of Conduct to regulate monitor and report Trading by insiders ("Code") and applicable SEBI Regulations we would like to inform you that trading window for dealing in the securities of the company by insiders stands closed from 01st April 2024 and will be re-opened 48 hours after the declaration of financial results for the financial and quarter ended 31st March 2024 to the stock exchanges. You are requested to kindly take the same on your record and acknowledge receipt. Thanking you. |
Fri, 26 Apr 2024 |
High Delivery Percentage |
Close Within 52 Week Low Zone |
High Decrease in 3 Months |
High Increase in 2 Years |
CCI Oversold Zone |